These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24158898)

  • 1. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.
    Nasa M; Choksey A; Phadke A; Sawant P
    Indian J Gastroenterol; 2013 Nov; 32(6):392-6. PubMed ID: 24158898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
    Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
    BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial.
    Vaira D; Zullo A; Vakil N; Gatta L; Ricci C; Perna F; Hassan C; Bernabucci V; Tampieri A; Morini S
    Ann Intern Med; 2007 Apr; 146(8):556-63. PubMed ID: 17438314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
    Sardarian H; Fakheri H; Hosseini V; Taghvaei T; Maleki I; Mokhtare M
    Helicobacter; 2013 Apr; 18(2):129-34. PubMed ID: 23121338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.
    Scaccianoce G; Hassan C; Panarese A; Piglionica D; Morini S; Zullo A
    Can J Gastroenterol; 2006 Feb; 20(2):113-7. PubMed ID: 16482238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial.
    Javid G; Zargar SA; Bhat K; Khan BA; Yatoo GN; Gulzar GM; Shah AH; Sodhi JS; Khan MA; Shoukat A; Saif RU
    Indian J Gastroenterol; 2013 May; 32(3):190-4. PubMed ID: 23515980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
    Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.
    Choi HS; Chun HJ; Park SH; Keum B; Seo YS; Kim YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS
    World J Gastroenterol; 2012 May; 18(19):2377-82. PubMed ID: 22654429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
    De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
    Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
    Choi IJ; Jung HC; Choi KW; Kim JH; Ahn DS; Yang US; Rew JS; Lee SI; Rhee JC; Chung IS; Chung JM; Hong WS
    Aliment Pharmacol Ther; 2002 Jan; 16(1):145-51. PubMed ID: 11856089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study.
    Seddik H; Ahid S; El Adioui T; El Hamdi FZ; Hassar M; Abouqal R; Cherrah Y; Benkirane A
    Eur J Clin Pharmacol; 2013 Sep; 69(9):1709-15. PubMed ID: 23695545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.
    Federico A; Nardone G; Gravina AG; Iovene MR; Miranda A; Compare D; Pilloni PA; Rocco A; Ricciardiello L; Marmo R; Loguercio C; Romano M
    Gastroenterology; 2012 Jul; 143(1):55-61.e1; quize e13-4. PubMed ID: 22484118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
    Bochenek WJ; Peters S; Fraga PD; Wang W; Mack ME; Osato MS; El-Zimaity HM; Davis KD; Graham DY;
    Helicobacter; 2003 Dec; 8(6):626-42. PubMed ID: 14632678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
    De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
    Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
    Hassan C; De Francesco V; Zullo A; Scaccianoce G; Piglionica D; Ierardi E; Panella C; Morini S
    Aliment Pharmacol Ther; 2003 Sep; 18(6):641-6. PubMed ID: 12969091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
    Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.